Celecoxib, DFMO combination improved adenoma burden in patients with familial adenomatous polyposis | oneFAPvoice

welcome to oneFAPvoice

- a positively charged Familial Adenomatous Polyposis community.
  • join today!

Celecoxib, DFMO combination improved adenoma burden in patients with familial adenomatous polyposis


In a randomized clinical chemoprevention trial, a combination of celecoxib and diflouromethylornithine resulted in a nonsignificant benefit among patients with familial adenomatous polyposis when adenoma count in a defined area was used as the primary endpoint. However, the combination was well tolerated, and a secondary measure of adenoma burden using a video-based global assessment showed a significant incremental benefit.

https://media-www.fapvoice.com/wp-content/uploads/2016/04/17.jpg